Press Releases

Date	Title	PDF Version
Apr 08, 2010	Alexion Pharmaceuticals to Report First Quarter Results on Thursday, April 22, 2010
Mar 02, 2010	Alexion to Present at the Cowen and Company 30th Annual Health Care Conference
Feb 26, 2010	Alexion Joins NORD, EURORDIS and Other Patient Advocacy Groups in Supporting the Goals of Rare Disease Day 2010
Feb 24, 2010	Alexion Appoints Andreas Rummelt to its Board of Directors
Feb 11, 2010	Alexion Reports Fourth Quarter and Full Year 2009 Results
Jan 28, 2010	Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2009 Results on February 11, 2010
Jan 06, 2010	Alexion to Present at the 28th Annual JP Morgan Healthcare Conference
Dec 07, 2009	Soliris(R) Reduced Hemolysis, Lowered Thrombosis Rate and Improved Quality of Life in Patients with PNH Who Had Previously Never Been Transfused
Dec 07, 2009	Soliris® Reversed Thrombocytopenia in Patients with Both PNH and Pre-Existing Thrombocytopenia in Study Presented at ASH Annual Meeting
Dec 06, 2009	Soliris(R) Reduced Hemolysis, Decreased Transfusion Requirements and Improved Fatigue in Patients with PNH and Bone Marrow Insufficiency Disorders

Search